Filament Health Corp

Filament Health Announces Annual General Meeting Voting Results
Vancouver, British Columbia--(Newsfile Corp. - November 8, 2023) - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its Annual General Meeting ("AGM") of shareholders held virtually this morning. At the AGM, there were 18 holders of common shares of Filament (the "Common Shares") represented in person or by proxy, holding 81,649,327 Common Shares and representing 40.28%...
2023-11-08 3:20 PM EST
Filament Ventures Corp. and 1287396 B.C. Ltd. Announce Execution of Amalgamation Agreement and Conditional Approval of the NEO Exchange Inc.
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2021) - 1287396 B.C. Ltd. ("396") and Filament Ventures Corp. ("Filament") are pleased to announce that further to the press release of Filament dated May 17, 2021, 396 and Filament have entered into an amalgamation agreement dated June 7, 2021 (the "Amalgamation Agreement") and have received conditional acceptance from the NEO Exchange Inc. ("NEO") for the closing of the proposed amalgamation of Filament and 396 (the "Amalgamation").The Amalgamation Agreement provides for the Amalgamation,...
2021-06-08 4:46 PM EDT